Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients (Q57601974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

0 references

relapsing-remitting multiple sclerosis

0 references

author

Jordi Rio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Mar Tintoré

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Ingrid Galán

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Xavier Montalban

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Carlos Nos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Nieves Téllez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Raúl Pelayo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Manuel Comabella

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

344-352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

16 January 2020

cites work

1 reference

HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

Identifying and treating patients with suboptimal responses

21 January 2018

1 reference

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.20740

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437558%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference